Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34


Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.

Schochter F, Rack B, Tzschaschel M, Polasik A, Andergassen U, Trapp E, Alunni-Fabbroni M, Schneeweiss A, Müller V, Pantel K, Gade J, Lorenz R, Rezai M, Tesch H, Soeling U, Fehm T, Mahner S, Schindlbeck C, Lichtenegger W, Beckmann MW, Fasching PA, Janni W, Friedl TWP; SUCCESS Study Group.

Oncol Res Treat. 2018;41(3):93-98. doi: 10.1159/000485566. Epub 2018 Feb 27.


Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.

Alunni-Fabbroni M, Majunke L, Trapp EK, Tzschaschel M, Mahner S, Fasching PA, Fehm T, Schneeweiss A, Beck T, Lorenz R, Friedl TWP, Janni W, Rack B; SUCCESS Study Group.

BMC Cancer. 2018 Feb 6;18(1):141. doi: 10.1186/s12885-018-4020-7.


Methylation patterns in serum DNA for early identification of disseminated breast cancer.

Widschwendter M, Evans I, Jones A, Ghazali S, Reisel D, Ryan A, Gentry-Maharaj A, Zikan M, Cibula D, Eichner J, Alunni-Fabbroni M, Koch J, Janni WJ, Paprotka T, Wittenberger T, Menon U, Wahl B, Rack B, Lempiäinen H.

Genome Med. 2017 Dec 22;9(1):115. doi: 10.1186/s13073-017-0499-9.


Quantifying HER-2 expression on circulating tumor cells by ACCEPT.

Zeune L, van Dalum G, Decraene C, Proudhon C, Fehm T, Neubauer H, Rack B, Alunni-Fabbroni M, Terstappen LWMM, van Gils SA, Brune C.

PLoS One. 2017 Oct 30;12(10):e0186562. doi: 10.1371/journal.pone.0186562. eCollection 2017.


LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.

Trapp EK, Majunke L, Zill B, Sommer H, Andergassen U, Koch J, Harbeck N, Mahner S, Friedl TWP, Janni W, Rack B, Alunni-Fabbroni M.

Mol Oncol. 2017 Nov;11(11):1508-1526. doi: 10.1002/1878-0261.12111. Epub 2017 Sep 30.


Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.

Schramm A, Schochter F, Friedl TWP, de Gregorio N, Andergassen U, Alunni-Fabbroni M, Trapp E, Jaeger B, Heinrich G, Camara O, Decker T, Ober A, Mahner S, Fehm TN, Pantel K, Fasching PA, Schneeweiss A, Janni W, Rack BK; SUCCESS Study Group.

Clin Breast Cancer. 2017 Jul;17(4):279-285. doi: 10.1016/j.clbc.2016.11.008. Epub 2017 Jan 10.


Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.

Hepp P, Andergassen U, Jäger B, Trapp E, Alunni-Fabbroni M, Friedl TW, Hecker N, Lorenz R, Fasching P, Schneeweiss A, Fehm T, Janni W, Rack B.

Anticancer Res. 2016 Sep;36(9):4771-6.


CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.

Rack B, Jückstock J, Trapp E, Weissenbacher T, Alunni-Fabbroni M, Schramm A, Widschwendter P, Lato K, Zwingers T, Lorenz R, Tesch H, Schneeweiss A, Fasching P, Mahner S, Beckmann MW, Lichtenegger W, Janni W; SUCCESS Study Group.

Tumour Biol. 2016 Oct;37(10):13769-13775. Epub 2016 Aug 1.


Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.

Jueckstock J, Rack B, Friedl TW, Scholz C, Steidl J, Trapp E, Tesch H, Forstbauer H, Lorenz R, Rezai M, Häberle L, Alunni-Fabbroni M, Schneeweiss A, Beckmann MW, Lichtenegger W, Fasching PA, Pantel K, Janni W; SUCCESS Study Group.

BMC Cancer. 2016 Jul 7;16:401. doi: 10.1186/s12885-016-2454-3.


Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.

König A, Vilsmaier T, Rack B, Friese K, Janni W, Jeschke U, Andergassen U, Trapp E, Jückstock J, Jäger B, Alunni-Fabbroni M, Friedl T, Weissenbacher T; SUCCESS STUDY GROUP.

Anticancer Res. 2016 Jun;36(6):3123-30.


Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.

Rack B, Zombirt E, Trapp E, Jückstock J, Andergassen U, Neugebauer J, Kost B, Weissenbacher T, Jeschke U, Schindlbeck C, Janni W, Alunni-Fabbroni M.

Oncology. 2016;90(4):232-8. doi: 10.1159/000442986. Epub 2016 Mar 4.


The Single-Cell Lab or How to Perform Single-Cell Molecular Analysis.

Kirchner R, Alunni-Fabbroni M.

Methods Mol Biol. 2015;1347:43-55. doi: 10.1007/978-1-4939-2990-0_3. Review.


Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.

Schramm A, Friedl TW, Schochter F, Scholz C, de Gregorio N, Huober J, Rack B, Trapp E, Alunni-Fabbroni M, Müller V, Schneeweiss A, Pantel K, Meier-Stiegen F, Hartkopf A, Taran FA, Wallwiener D, Janni W, Fehm T.

Arch Gynecol Obstet. 2016 Feb;293(2):271-81. doi: 10.1007/s00404-015-3879-7. Epub 2015 Sep 9.


Genetic analysis of circulating tumor cells in pancreatic cancer patients: A pilot study.

Görner K, Bachmann J, Holzhauer C, Kirchner R, Raba K, Fischer JC, Martignoni ME, Schiemann M, Alunni-Fabbroni M.

Genomics. 2015 Jul;106(1):7-14. doi: 10.1016/j.ygeno.2015.02.003. Epub 2015 Mar 24.


DNA methylation markers for early detection of women's cancer: promise and challenges.

Wittenberger T, Sleigh S, Reisel D, Zikan M, Wahl B, Alunni-Fabbroni M, Jones A, Evans I, Koch J, Paprotka T, Lempiäinen H, Rujan T, Rack B, Cibula D, Widschwendter M.

Epigenomics. 2014 Jun;6(3):311-27. doi: 10.2217/epi.14.20. Review.


Monitoring in metastatic breast cancer: is imaging outdated in the era of circulating tumor cells?

Alunni-Fabbroni M, Müller V, Fehm T, Janni W, Rack B.

Breast Care (Basel). 2014 Feb;9(1):16-21. doi: 10.1159/000360438. Review.


Evaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancer.

Jaeger BA, Jueckstock J, Andergassen U, Salmen J, Schochter F, Fink V, Alunni-Fabbroni M, Rezai M, Beck T, Beckmann MW, Friese K, Friedl TW, Janni W, Rack B.

Biomed Res Int. 2014;2014:491459. doi: 10.1155/2014/491459. Epub 2014 Apr 8.


Detection of chromosomal aneuploidies in fetal cells isolated from maternal blood using single-chromosome dual-probe FISH analysis.

Calabrese G, Baldi M, Fantasia D, Sessa MT, Kalantar M, Holzhauer C, Alunni-Fabbroni M, Palka G, Sitar G.

Clin Genet. 2012 Aug;82(2):131-9. doi: 10.1111/j.1399-0004.2011.01775.x. Epub 2011 Oct 14.


A high-throughput DNA methylation analysis of a single cell.

Kantlehner M, Kirchner R, Hartmann P, Ellwart JW, Alunni-Fabbroni M, Schumacher A.

Nucleic Acids Res. 2011 Apr;39(7):e44. doi: 10.1093/nar/gkq1357. Epub 2011 Jan 25.


Circulating tumour cells in clinical practice: Methods of detection and possible characterization.

Alunni-Fabbroni M, Sandri MT.

Methods. 2010 Apr;50(4):289-97. doi: 10.1016/j.ymeth.2010.01.027. Epub 2010 Jan 29. Review.


Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6.

Fiesel FC, Voigt A, Weber SS, Van den Haute C, Waldenmaier A, Görner K, Walter M, Anderson ML, Kern JV, Rasse TM, Schmidt T, Springer W, Kirchner R, Bonin M, Neumann M, Baekelandt V, Alunni-Fabbroni M, Schulz JB, Kahle PJ.

EMBO J. 2010 Jan 6;29(1):209-21. doi: 10.1038/emboj.2009.324. Epub 2009 Nov 12.


Automatic retrieval of single microchimeric cells and verification of identity by on-chip multiplex PCR.

Kroneis T, Gutstein-Abo L, Kofler K, Hartmann M, Hartmann P, Alunni-Fabbroni M, Walcher W, Dohr G, Petek E, Guetta E, Sedlmayr P.

J Cell Mol Med. 2010 Apr;14(4):954-69. doi: 10.1111/j.1582-4934.2009.00784.x. Epub 2009 May 19.


Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1.

Waak J, Weber SS, Waldenmaier A, Görner K, Alunni-Fabbroni M, Schell H, Vogt-Weisenhorn D, Pham TT, Reumers V, Baekelandt V, Wurst W, Kahle PJ.

FASEB J. 2009 Aug;23(8):2478-89. doi: 10.1096/fj.08-125153. Epub 2009 Mar 10.


Identification of a novel activity of human papillomavirus type 16 E6 protein in deregulating the G1/S transition.

Malanchi I, Caldeira S, Krützfeldt M, Giarre M, Alunni-Fabbroni M, Tommasino M.

Oncogene. 2002 Aug 22;21(37):5665-72.


Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes.

Reshkin SJ, Bellizzi A, Caldeira S, Albarani V, Malanchi I, Poignee M, Alunni-Fabbroni M, Casavola V, Tommasino M.

FASEB J. 2000 Nov;14(14):2185-97.


Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.

Alunni-Fabbroni M, Littlewood T, Deleu L, Caldeira S, Giarrè M, Dell' Orco M, Tommasino M.

Oncogene. 2000 May 4;19(19):2277-85.


Separation of C/EBPalpha-mediated proliferation arrest and differentiation pathways.

Müller C, Alunni-Fabbroni M, Kowenz-Leutz E, Mo X, Tommasino M, Leutz A.

Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7276-81.


Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions.

Zehbe I, Rätsch A, Alunni-Fabbroni M, Burzlaff A, Bakos E, Dürst M, Wilander E, Tommasino M.

Oncogene. 1999 Apr 1;18(13):2201-11.


Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition.

Xodo L, Alunni-Fabbroni M, Manzini G, Quadrifoglio F.

Nucleic Acids Res. 1994 Aug 25;22(16):3322-30.


Sequence-specific DNA-triplex formation at imperfect homopurine-homopyrimidine sequences within a DNA plasmid.

Xodo LE, Alunni-Fabbroni M, Manzini G, Quadrifoglio F.

Eur J Biochem. 1993 Mar 1;212(2):395-401.

Supplemental Content

Loading ...
Support Center